The majority of drugs that enter Phase III end up getting approved by the FDA. While final approval might still be some time away, the near-certainty of approval warrants manufacturers at Phase III to begin completing the legwork needed to bring a drug to the market. On top of additional Market Access and Market Intelligence initiatives, you also need to begin the long list of Commercialization activities that need completed.

That includes beginning to develop your channel strategy, starting the state licensing process, getting your drug listed in compendia databases, and much more.